Current Trends and Future Strategies on Diagnosis and Management of Adenomyosis: An Updated Review

Author:

Bee Rizwana1,Ahmad Mohammad2,Verma Shashi1,Tiwari Ritesh kumar1

Affiliation:

1. Shri Ram Murti Smarak College of Engineering & Technology (Pharmacy) Bareilly, Uttar Pradesh 243202, India

2. Department of Pharmacy, Integral University Lucknow. India

Abstract

Abstract: This aim of the study was to gather information for use in the present and future management of the adenomyosis condition. Adenomyosis is a benign gynecological condition that needs to be managed for the rest of one's life with either medication or surgical treatment. It is also associated with abnormal uterine bleeding, dysmenorrhea, dyspareunia, and infertility. The choice a woman makes will be influenced by her age, reproductive status, and clinical indicators. The primary goals of this study were to gain knowledge on adenomyosis and to review potential treatment possibilities. According to this review, adenomyosis can be treated in a number of ways, including through medical attention utilizing least-invasive techniques a surgical operation that is performed with minimally invasive techniques. Focused ultrasound with high intensity (HIFU) for hysteroscopic ablation and resection Embolishing the uterine artery (UAE). Adenomyosis is a benign gynecological illness that necessitates a lifelong care strategy by medication or surgical therapy and is accompanied by abnormal uterine hemorrhage, dysmenorrhea, dyspareunia, and infertility. The option a woman chooses will depend on her age, reproductive status, and clinical signs. Since there is currently no medication approved for the treatment of adenomyosis, the present review will focus on existing and future medical procedures for the condition. The uterus is impacted by the medical condition adenomyosis. It happens when the endometrial tissue that normally lines the uterus invades the myometrium, the uterine muscle wall. Although this illness is benign, some people may experience substantial pain and discomfort as a result of it. It is more typically detected in those who have had children and is most frequently diagnosed in people between the ages of 30 and 50. Treatment options depend on the severity of symptoms and the individual's specific situation. Treatment approaches may include Pain Management, Hormonal Therapy, Surgical Interventions, Surgical Interventions and Lifestyle Changes. Several uterine-sparing therapeutic alternatives are currently available, each with unique risks and benefits, such as medication, hysteroscopic resection or ablation, conservative surgical methods, and high-intensity focused ultrasound. Uterine artery embolization, a practical, secure, and cost-effective method for treating uterine fibroids, has recently grown in popularity as a treatment for uterine adenomyosis.

Publisher

Bentham Science Publishers Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3